0001437749-23-030229.txt : 20231103 0001437749-23-030229.hdr.sgml : 20231103 20231103163137 ACCESSION NUMBER: 0001437749-23-030229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231103 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paula Molina Rene CENTRAL INDEX KEY: 0001890868 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 231376864 MAIL ADDRESS: STREET 1: C/O VAXXINITY, INC. STREET 2: 1717 MAIN ST STE. 3388 CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 4 1 rdgdoc.xml FORM 4 X0508 4 2023-11-03 1 0001851657 Vaxxinity, Inc. VAXX 0001890868 Paula Molina Rene C/O VAXXINITY, INC. 505 ODYSSEY WAY MERRITT ISLAND FL 32953 1 See Remarks 0 Mr. Paula Molina resigned effective November 3, 2023. His title was SVP, Legal & Business Affairs (General Counsel). As a result, Mr. Paula Molina is no longer subject to Section 16 of the Securities Exchange Act of 1934 in connection with his transactions in the equity securities of Vaxxinity, Inc. and, therefore, will no longer report any such transactions on Form 4 or Form 5. /s/ Rene Paula Molina 2023-11-03